Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Other Accumulated Expenses (2009 - 2026)

Updated

Bristol Myers Squibb (BMY) posted Other Accumulated Expenses of $13.1 billion for Q3 2026, down 32.3% from $19.34 billion a year earlier and down 2.8% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Other Accumulated Expenses (2009 - 2026) Analysis & Trends

At the end of FY2025, Bristol Myers Squibb's Other Accumulated Expenses came in at $17.58 billion, down 3.0% from FY2024.

  • Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 4.6% (FY2020 to FY2025).
  • In prior years, Bristol Myers Squibb's Other Accumulated Expenses was $18.13 billion in FY2024 (+14.1%), $15.88 billion in FY2023 (+8.9%), $14.59 billion in FY2022 (+4.4%) and $13.97 billion in FY2021 (-0.4%).
  • Quarterly Other Accumulated Expenses has run from a low of $12.36 billion in Q1 2022 to a high of $19.34 billion in Q3 2025 over five years.
  • On a year-over-year basis, Other Accumulated Expenses has declined in each of the last four quarters, with an average decline of 6.1% over the last eight quarters.
  • The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q1 2024, with growth of 22.5%; the weakest was Q3 2026, with a decline of 32.3%.
  • According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $13.47 billion (Q2 2026), $12.62 billion (Q1 2026) and $17.58 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 13.10 Bn
Jun 30, 2026 13.47 Bn
Mar 31, 2026 12.62 Bn
Dec 31, 2025 17.58 Bn
Sep 30, 2025 19.34 Bn
Jun 30, 2025 17.39 Bn
Mar 31, 2025 16.51 Bn
Dec 31, 2024 18.13 Bn
Sep 30, 2024 18.09 Bn
Jun 30, 2024 15.98 Bn
Mar 31, 2024 16.09 Bn
Dec 31, 2023 15.88 Bn
Sep 30, 2023 15.18 Bn
Jun 30, 2023 14.06 Bn
Mar 31, 2023 13.14 Bn
Dec 31, 2022 14.59 Bn
Sep 30, 2022 14.20 Bn
Jun 30, 2022 13.08 Bn
Mar 31, 2022 12.36 Bn
Dec 31, 2021 13.97 Bn
API Access

Bristol Myers Squibb Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BMY&period=max&api_key=YOUR_API_KEY